Glaxosmithkline Pharmaceuticals Share Price

ABOUT Glaxosmithkline Pharmaceuticals

• Industry Biotechnology & Drugs
• ISIN INE159A01016
• BSE Code 500660
• NSE Code GLAXO

GlaxoSmithKline Pharmaceuticals Limited is an India-based global healthcare company. The Company is engaged in the business of manufacturing, distributing and trading in pharmaceuticals. The Company has three product areas: vaccines, specialty and general medicine. Its general medicines business has a portfolio of medicines in anti-infectives, pain, vitamins medicine, nutritional, hormones, dermatologicals, respiratory and vaccines for adults and children. The Company's general medicine brands include Augmentin, Calpol, Ceftum, Eltroxin, CCM, Neosporin, Betnovate, Tenovate, T-bact and Physiogel. The Company's vaccine brands include Shingrix Herpes Zoster Vaccine, Infanrix Hexa, Synflorix, Boostrix, Havrix, Menveo, Fluarix Tetra and Varilrix. Its specialty medicine brands include Nucala, Seretide, and Trelegy Ellipta. Trelegy Ellipta, single inhaler triple therapy (SITT) for chronic obstructive pulmonary disease (COPD) patients. The Subsidiary of the Company is Biddle Sawyer Limited.

MANAGEMENT

• Juby Chandy Chief Financial Officer, Whole Time Director
• Chinmay Sharma Executive Vice President of Human Resources
• S. Choudhary Executive Vice President - Regulatory Affairs
• Ransom D'Souza Executive Vice President - Communications and Government Affairs
• Shalini Menon Executive Vice President - Medical Affairs
• Shourov Mukherjee Executive Vice President - Adult Vaccines
• Amit Pandey Executive Vice President - Legal
• Upendra Singh Executive Vice President - General Medicines
• Ritesh Manchanda Vice President - Customer Supply Chain
• Sharmishta Mitra Vice President - Paediatric Vaccines